Chen et al. and Garufi et al. reported that GV inhibits NOX and upregulates p53 in liver cancer cells (SK-HEP-1 and SMMC-7721), lung cancer cells (H1299), and colon cancer cells (RKO and HCT116) [15,16]. Here, TP53 is linked to malignant colon neoplasm.